MAPT and Alzheimer disease: Moreover, Kim N.G. et al. [52] used iPSCs from patients with AD to generate cortical brain organoids expressing AD phenotypes, including amyloid β and hyperphosphorylated tau accumulation, both of which are hallmark features of AD.